Structure-based maximal affinity model predicts small-molecule druggability
- PMID: 17211405
- DOI: 10.1038/nbt1273
Structure-based maximal affinity model predicts small-molecule druggability
Abstract
Lead generation is a major hurdle in small-molecule drug discovery, with an estimated 60% of projects failing from lack of lead matter or difficulty in optimizing leads for drug-like properties. It would be valuable to identify these less-druggable targets before incurring substantial expenditure and effort. Here we show that a model-based approach using basic biophysical principles yields good prediction of druggability based solely on the crystal structure of the target binding site. We quantitatively estimate the maximal affinity achievable by a drug-like molecule, and we show that these calculated values correlate with drug discovery outcomes. We experimentally test two predictions using high-throughput screening of a diverse compound collection. The collective results highlight the utility of our approach as well as strategies for tackling difficult targets.
Similar articles
-
Binding site detection and druggability index from first principles.J Med Chem. 2009 Apr 23;52(8):2363-71. doi: 10.1021/jm801385d. J Med Chem. 2009. PMID: 19296650
-
Druggability indices for protein targets derived from NMR-based screening data.J Med Chem. 2005 Apr 7;48(7):2518-25. doi: 10.1021/jm049131r. J Med Chem. 2005. PMID: 15801841
-
Form follows function: shape analysis of protein cavities for receptor-based drug design.Proteomics. 2009 Jan;9(2):451-9. doi: 10.1002/pmic.200800092. Proteomics. 2009. PMID: 19142949
-
Structure-based druggability assessment--identifying suitable targets for small molecule therapeutics.Curr Opin Chem Biol. 2011 Aug;15(4):463-8. doi: 10.1016/j.cbpa.2011.05.020. Epub 2011 Jun 23. Curr Opin Chem Biol. 2011. PMID: 21704549 Review.
-
Informatics and modeling challenges in fragment-based drug discovery.Curr Opin Drug Discov Devel. 2007 May;10(3):289-97. Curr Opin Drug Discov Devel. 2007. PMID: 17554855 Review.
Cited by
-
Heterogeneous network propagation with forward similarity integration to enhance drug-target association prediction.PeerJ Comput Sci. 2022 Oct 11;8:e1124. doi: 10.7717/peerj-cs.1124. eCollection 2022. PeerJ Comput Sci. 2022. PMID: 36262151 Free PMC article.
-
Druggability Analysis of Protein Targets for Drug Discovery to Combat Listeria monocytogenes.Microorganisms. 2024 May 25;12(6):1073. doi: 10.3390/microorganisms12061073. Microorganisms. 2024. PMID: 38930455 Free PMC article.
-
An overview of recent advances and challenges in predicting compound-protein interaction (CPI).Med Rev (2021). 2023 Oct 6;3(6):465-486. doi: 10.1515/mr-2023-0030. eCollection 2023 Dec. Med Rev (2021). 2023. PMID: 38282802 Free PMC article. Review.
-
The druggable genome: Twenty years later.Front Bioinform. 2022 Sep 30;2:958378. doi: 10.3389/fbinf.2022.958378. eCollection 2022. Front Bioinform. 2022. PMID: 36304325 Free PMC article.
-
Overcoming Chemical, Biological, and Computational Challenges in the Development of Inhibitors Targeting Protein-Protein Interactions.Chem Biol. 2015 Jun 18;22(6):689-703. doi: 10.1016/j.chembiol.2015.04.019. Chem Biol. 2015. PMID: 26091166 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical